NYSCF

AcronymDefinition
NYSCFNew York Stem Cell Foundation
NYSCFNew York State Cavy Fanciers (rodents)
References in periodicals archive ?
The NYSCF is specifically recognizing Melson for his dedication and support of Team Fight to Walk, mentoring at risk youths and excellence as an athlete.
We feel that examination of disease relevant cell-types made from patient-specific stem cells represents an important step in the ever evolving process of drug discovery and have identified this collaboration with NYSCF and their automated iPS cell derivation technology as an opportunity to ruggedize our internal development pipeline .
We are very excited to welcome NYSCF to the building and congratulate them on building a world-class research center right here on the burgeoning west side of Manhattan," said Paul Pariser, co-CEO of Taconic.
NYSCF and Q-State with this agreement insist their commitment to patients awaiting cures.
Marolt has continued to build upon this research as an Investigator in the NYSCF Laboratory, developing bone grafts from induced pluripotent stem (iPS) cells.
NYSCF, a world leader in stem cell research and the development of pioneering stem cell technologies, will create a new state-of-the-art laboratory and research facility including office space, consolidating its current operations from two sites into one central location.
The NYSCF Global Stem Cell Array pushes biological research into the future, meeting the demands required to perform population-wide studies while enhancing experimental and statistical power.
Advances made earlier this year by NYSCF Research Institute scientists that showed that human embryonic stem cells could be derived using SCNT revived that debate.
In type 1 diabetes, the body's immune system attacks its own beta cells; therefore, further work is underway at NYSCF, Columbia, and other institutions to develop strategics to protect existing and therapeutic beta cells from attack by the immune system, as well as to prevent such attack.
co-author of the study and an Senior Researcher in the NYSCF Laboratory.
In type 1 diabetes, the body's immune system attacks its own beta cells; therefore, further work is underway at NYSCF, Columbia, and other institutions to develop strategies to protect existing and therapeutic beta cells from attack by the immune system, as well as to prevent such attack.
D, a NYSCF research fellow, could be a major advance in personalized reconstructive treatments for patients with bone defects resulting from disease or trauma.